Iowa State Bank Abb Vie Inc. Transaction History

Iowa State Bank

$481 Million
Q3 2024

A detailed history of Iowa State Bank transactions in Abb Vie Inc. stock. As of the latest transaction made, Iowa State Bank holds 53,097 shares of ABBV stock, worth $9.32 Million. This represents 2.18% of its overall portfolio holdings.

Number of Shares

53,097

Previous 51,288 3.53%

Holding current value

$9.32 Million

Previous $8.8 Million 19.2%

% of portfolio

2.18%

Previous 1.95%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 09, 2024	BUY	$163.84 - $199.33 $296,386 - $360,587	1,809 Added 3.53%	53,097 $10.5 Million
Q2 2024 Jul 23, 2024	BUY	$154.79 - $180.76 $80,181 - $93,633	518 Added 1.02%	51,288 $8.8 Million
Q1 2024 Apr 23, 2024	SELL	$159.82 - $182.1 $189,706 - $216,152	-1,187 Reduced 2.28%	50,770 $9.25 Million
Q4 2023 Jan 23, 2024	SELL	$137.6 - $154.97 $916,140 - $1.03 Million	-6,658 Reduced 11.36%	51,957 $8.05 Million
Q3 2023 Oct 24, 2023	BUY	$133.59 - $154.65 $110,612 - $128,050	828 Added 1.43%	58,615 $8.74 Million
Q2 2023 Aug 04, 2023	SELL	$132.51 - $164.9 $189,356 - $235,642	-1,429 Reduced 2.41%	57,787 $7.79 Million
Q1 2023 Apr 25, 2023	SELL	$144.61 - $166.54 $660,289 - $760,421	-4,566 Reduced 7.16%	59,216 $9.44 Million
Q4 2022 Jan 06, 2023	BUY	$138.31 - $165.87 $288,929 - $346,502	2,089 Added 3.39%	63,782 $10.3 Million
Q3 2022 Oct 14, 2022	SELL	$134.21 - $153.93 $294,456 - $337,722	-2,194 Reduced 3.43%	61,693 $8.28 Million
Q2 2022 Aug 05, 2022	SELL	$137.62 - $174.96 $181,796 - $231,122	-1,321 Reduced 2.03%	63,887 $9.79 Million
Q1 2022 Apr 27, 2022	SELL	$131.98 - $163.75 $373,239 - $463,085	-2,828 Reduced 4.16%	65,208 $10.6 Million
Q4 2021 Feb 02, 2022	BUY	$107.43 - $135.93 $364,080 - $460,666	3,389 Added 5.24%	68,036 $9.21 Million
Q3 2021 Oct 12, 2021	SELL	$106.4 - $120.78 $487,737 - $553,655	-4,584 Reduced 6.62%	64,647 $6.97 Million
Q2 2021 Aug 03, 2021	SELL	$105.21 - $117.21 $21,042 - $23,442	-200 Reduced 0.29%	69,231 $7.8 Million
Q1 2021 Apr 15, 2021	SELL	$102.3 - $112.62 $181,684 - $200,013	-1,776 Reduced 2.49%	69,431 $7.51 Million
Q4 2020 Feb 04, 2021	BUY	$80.49 - $108.67 $81,536 - $110,082	1,013 Added 1.44%	71,207 $7.63 Million
Q3 2020 Oct 19, 2020	BUY	$85.91 - $100.83 $494,669 - $580,579	5,758 Added 8.94%	70,194 $6.15 Million
Q2 2020 Jul 16, 2020	SELL	$73.37 - $98.18 $77,258 - $103,383	-1,053 Reduced 1.61%	64,436 $6.33 Million
Q1 2020 Apr 29, 2020	BUY	$64.5 - $97.79 $73,465 - $111,382	1,139 Added 1.77%	65,489 $4.99 Million
Q4 2019 Jan 21, 2020	BUY	$72.13 - $90.25 $96,582 - $120,844	1,339 Added 2.13%	64,350 $5.7 Million
Q3 2019 Oct 18, 2019	BUY	$62.98 - $75.72 $199,079 - $239,350	3,161 Added 5.28%	63,011 $4.77 Million
Q2 2019 Jul 10, 2019	BUY	$65.7 - $83.98 $2,562 - $3,275	39 Added 0.07%	59,850 $4.35 Million
Q1 2019 Apr 04, 2019	BUY	$77.14 - $90.79 $66,957 - $78,805	868 Added 1.47%	59,811 $4.82 Million
Q4 2018 Feb 13, 2019	BUY	$77.85 - $96.01 $21,642 - $26,690	278 Added 0.47%	58,943 $5.43 Million
Q3 2018 Oct 17, 2018	SELL	$88.91 - $98.84 $27,651 - $30,739	-311 Reduced 0.53%	58,665 $5.55 Million
Q2 2018 Jul 20, 2018	SELL	$89.78 - $106.23 $47,762 - $56,514	-532 Reduced 0.89%	58,976 $5.46 Million
Q1 2018 May 03, 2018	SELL	$92.01 - $123.21 $555,556 - $743,941	-6,038 Reduced 9.21%	59,508 $5.63 Million
Q4 2017 Feb 07, 2018	SELL	$89.56 - $98.21 $166,492 - $182,572	-1,859 Reduced 2.76%	65,546 $6.34 Million
Q3 2017 Oct 16, 2017	BUY	$69.85 - $89.22 $4.71 Million - $6.01 Million	67,405	67,405 $5.99 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Iowa State Bank, based on Form 13F filings with the SEC.

News

Stay updated on Iowa State Bank with notifications on news.

Account